Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1626295Generated: October 27, 2026

Benzenesulfonyl chloride → tert-Butyl 6-(3-(3-chloro-5-fluorophenylamino)-2-oxopiperidin-1-yl)-1,4-oxazepane-4-carboxylate

https://huagongshe.com/reaction/1626295

Reaction equation

Participants

RoleNameHCIDCharge
ReactantBenzenesulfonyl chlorideHCID 7369—
ReactantSodium hydrideHCID 24758—
ReactantLithium diisopropylamideHCID 2724682—
Reactant3-Chloro-5-fluoroanilineHCID 2734838—
ReactantTetrahydrofuran heptane ethylbenzolHCID 22742125—
ReactantTert-butyl 6-(2-oxopiperidin-1-yl)-1,4-oxazepane-4-carboxylateHCID 67034527—
SolventTetrahydrofuranHCID 8028—
Producttert-Butyl 6-(3-(3-chloro-5-fluorophenylamino)-2-oxopiperidin-1-yl)-1,4-oxazepane-4-carboxylateHCID 6798631259%

Reaction Conditions

Temperature-30 °C

Reaction Steps

To a solution of 6-(2-oxo-piperidin-1-yl)-perhydro-1,4-oxazepine-4-carboxylic acid tert-butyl ester 38.5 (0.31 g, 1.0 mmol) in THF (10 mL) at −78° C. was added dropwise 2.0 M LDA in heptane/THF/ethylbenzene (0.7 mL, 1.5 mmol) under nitrogen. The solution was allowed to warm to −30° C. for 1 h and then recooled to −78° C. prior to the dropwise addition of PhSO2Cl (0.15 mL, 1.1 mmol). The reaction was allowed to slowly warm to 10° C. and then quenched upon the addition NaHCO3 and extracted with EtOAc. The organic phase was washed with NaHCO3, brine and dried (MgSO4), filtered and concentrated in vacuo to afford a solid. The chloro intermediate was dissolved in THF (8.4 mL) and added to a suspension of 3-chloro-5-fluoro-phenylamine (0.15 g, 1.04 mmol) and sodium hydride (60% in mineral oil, 80 mg, 2.1 mmol) in THF (16 mL). The reaction mixture was heated to reflux for 90 minutes, cooled to room temperature, placed and quenched with MeOH, water, NaHCO3 and EtOAc. The organics phase was separated, washed with brine, dried (MgSO4), filtered and concentrated in vacuo to afford an oil. The oil was purified by silica gel chromatography (gradient MeOH/DCM) to afford the desired product (204 mg, 59%). LCMS, m/z 386.1 [M-tBu]+.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08785440B2
Source datasetuspto-grants-2014_07
ORD IDord-6224394f2e5743efb792c4e7cc69b867
Source noteuspto-grants-2014_07